OS (univariate analysis) | OS (multivariate analysis) | |||
---|---|---|---|---|
Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value | |
Age (>63.5 years) | 1.13 (0.37-3.46) | 0.823 | ||
Sex | ||||
Female | 1 (reference) | |||
Male | 2.56 (0.33-19.7) | 0.367 | ||
Operative method | ||||
Open | 1 (reference) | |||
Laparoscopy | 1.81 (0.62-5.29) | 0.277 | ||
Intent to treat | ||||
Palliative | 1 (reference) | |||
Cure | 0.30 (0.10-0.93) | 0.038 | ||
Synchronous metastasis | 2.15 (0.68-6.73) | 0.187 | 3.05(1.07-11.94) | 0.048 |
Site of metastasis | ||||
Single | 1 (reference) | |||
Both | 0.60 (0.07-5.07) | 0.64 | ||
Adrenal + other site | 1.19 (0.39-3.61) | 0.754 | ||
Site of primary tumor | ||||
Other | 1 (reference) | |||
Liver | 0.35 (0.05-2.51) | 0.301 | ||
Stomach | 0.26 (0.02-2.87) | 0.277 | ||
Kidney | 0.63 (0.09-4.41) | 0.648 | ||
Lung | 1.41 (0.34-5.75) | 0.626 | ||
Previous metastasectomy | ||||
No | 1 (reference) | |||
Yes | 0.04 (0–67.8) | 0.397 | ||
C-reactive protein (mg/dl) | ||||
≤1.0 | 1 (reference) | |||
>1 | 5.74 (1.24-26.5) | 0.025 | ||
Albumin (g/dl) | ||||
≥3.5 | 1 (reference) | |||
<3.5 | 1.96 (0.68-5.61) | 0.2 | ||
GPS | ||||
0 | 1 (reference) | 1 (reference) | ||
1 | 3.28 (0.60-17.8) | 0.168 | 2.54 (0.46-14.26) | 0.288 |
2 | 5.33 (1.09-26.0) | 0.039 | 6.65 (1.25-35.23) | 0.026 |
ECOG-PS | ||||
0-1 | 1 (reference) | |||
2 | 1.81 (0.49-6.62) | 0.368 |